https://pharminent.com/oncology/oncology-intelligence-digest-may-8-2026/ 2026-05-09T01:34:42Z Pharminent en Oncology Intelligence Digest • May 8, 2026 2026-05-09T01:34:38Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-may-8-2026/ 2026-05-08T22:07:22Z Pharminent en GLP-1 Competitive Market Digest • Weekly • May 8, 2026 2026-05-08T22:07:17Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-may-8-2026/ 2026-05-08T21:42:04Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • May 8, 2026 2026-05-08T21:41:59Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-8-2026/ 2026-05-08T21:39:11Z Pharminent en Strategic News Watch • May 8, 2026 2026-05-08T21:39:05Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-may-7-2026/ 2026-05-07T22:58:32Z Pharminent en Rare Disease & Gene Therapy Digest • May 7, 2026 2026-05-07T22:58:28Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-may-7-2026/ 2026-05-07T17:09:07Z Pharminent en Strategic News Watch • May 7, 2026 2026-05-07T17:09:03Z Blog https://pharminent.com/angelini-inks-4-1b-catalyst-buy-to-enter-us-rare-disease-market/ 2026-05-07T15:56:15Z Pharminent en Angelini inks $4.1B Catalyst buy to enter US rare disease market 2026-05-07T14:46:04Z Blog https://pharminent.com/bayer-plans-filings-for-cardiac-amyloidosis-imaging-agent/ 2026-05-07T15:56:18Z Pharminent en Bayer plans filings for cardiac amyloidosis imaging agent 2026-05-07T12:53:11Z Blog https://pharminent.com/roche-buys-ai-powered-diagnostics-player-pathai/ 2026-05-07T15:56:20Z Pharminent en Roche buys AI-powered diagnostics player PathAI 2026-05-07T11:40:36Z Blog https://pharminent.com/ucb-and-cancer-research-uk-form-expanded-alliance-to-advance-novel-cancer-therapies/ 2026-05-08T16:00:29Z Pharminent en UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies 2026-05-07T10:35:55Z Blog https://pharminent.com/eli-lilly-pledges-4-5bn-to-bolster-indiana-based-manufacturing/ 2026-05-08T15:59:36Z Pharminent en Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing 2026-05-07T10:30:55Z Blog https://pharminent.com/daiichi-sankyo-and-waiv-partner-for-adc-biomarkers-2/ 2026-05-07T16:27:26Z Pharminent en Daiichi Sankyo and Waiv partner for ADC biomarkers 2026-05-07T09:03:01Z Blog https://pharminent.com/halozyme-and-oruka-sign-agreement-for-hypercon-technology-2/ 2026-05-07T21:37:02Z Pharminent en Halozyme and Oruka sign agreement for Hypercon technology 2026-05-07T08:07:28Z Blog